Protagonist Therapeutics Inc (PTGX)

Inventory turnover

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Cost of revenue (ttm) US$ in thousands 39,796 33,491 32,071 31,310 29,829 31,739 32,367 32,722 31,746 27,196 24,930 22,565 20,027 18,638 17,751 16,875 16,561 15,749 15,159 14,505
Inventory US$ in thousands -2,050 -50 -51 -94 -620 7,729 8,503 3,976 10 10 10 4,795 10 10
Inventory turnover 4.11 3.20 4.69 1,775.10 1,687.50 1,656.10 3.28 1,515.90 1,450.50

March 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $39,796K ÷ $—K
= —

Inventory turnover for Protagonist Therapeutics Inc has shown fluctuations over the past quarters, indicating varying efficiencies in managing its inventory. The company's inventory turnover ratio ranged from a low of 1.515.90 in September 2019 to a high of 1,775.10 in September 2020. Notably, the high turnover in September 2020 may suggest that the company effectively sold through its inventory multiple times during that period.

It is important to highlight the extreme values observed in 2020, specifically in March and September. These values, notably 1,775.10 and 1,687.50, may be outliers or data errors given the substantial deviation from the typical ranges of inventory turnover ratios seen in the industry.

Additionally, the inventory turnover ratio for the most recent quarters (up to March 2022) fell within the range of 3.20 to 4.69, indicating that the company has shown relatively consistent inventory management efficiency during this period. However, the absence of data for some quarters in between further limits the ability to track the trend of inventory turnover over time.

Overall, Protagonist Therapeutics Inc should aim to maintain a steady and optimal level of inventory turnover to ensure effective management of its inventory and efficient operations.


Peer comparison

Mar 31, 2024

Mar 31, 2024